<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>#024: March 23, 2021 - Longevity Marketcap Telemetry - Hex Index</title>
  <link rel="stylesheet" href="../../styles.css">
</head>
<body class="reading-mode">
  <header class="reading-header">
    <a href="../../index.html" class="back-link">&larr; Back to Library</a>
  </header>
  <main class="reading-content">
    
    <article class="article-page">
      <header class="article-header">
        <h1>#024: March 23, 2021 - Longevity Marketcap Telemetry</h1>
        <div class="article-meta">
          <span class="author">By Nathan Cheng</span>
          <span class="separator">&middot;</span>
          <a href="../../publication/longevitymarketcap/index.html" class="publication">
            Longevity Marketcap
          </a>
          <span class="separator">&middot;</span><time>Mar 23, 2021</time>
          <span class="separator">&middot;</span>
          <span class="read-time">11 min read</span>
        </div>
      </header>

      

      <div class="article-excerpt">
        <h1>Longevity Marketcap Telemetry (March 23nd, 2021)</h1><div class="captioned-image-container"><figure><a class="image-link image2 is-viewable-img" target="_blank" href="https://substackcdn.com/image/fetch/$s_!S2hP!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fbucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com%2Fpublic%2Fimages%2F3c913dcc-b869-4a26-a6a5-9018e64a4549_1200x500.png" data-component-name="Image2ToDOM"><div class="image2-inset"><picture><source type="image/webp" srcset="https://substackcdn.com/image/fetch/$s_!S2hP!,w_424,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fbucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com%2Fpublic%2Fimages%2F3c913dcc-b869-4a26-a6a5-9018e64a4549_1200x500.png 424w, https://substackcdn.com/image/fetch/$s_!S2hP!,w_848,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fbucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com%2Fpublic%2Fimages%2F3c913dcc-b869-4a26-a6a5-9018e64a4549_1200x500.png 848w, https://substackcdn.com/image/fetch/$s_!S2hP!,w_1272,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fbucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com%2Fpublic%2Fimages%2F3c913dcc-b869-4a26-a6a5-9018e64a4549_1200x500.png 1272w, https://substackcdn.com/image/fetch/$s_!S2hP!,w_1456,c_limit,f_webp,q_auto:good,fl_progressive:steep/https%3A%2F%2Fbucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com%2Fpublic%2Fimages%2F3c913dcc-b869-4a26-a6a5-9018e64a4549_1200x500.png 1456w" sizes="100vw"><img src="https://substackcdn.com/image/fetch/$s_!S2hP!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fbucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com%2Fpublic%2Fimages%2F3c913dcc-b869-4a26-a6a5-9018e64a4549_1200x500.png" width="1200" height="500" data-attrs="{&quot;src&quot;:&quot;https://bucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com/public/images/3c913dcc-b869-4a26-a6a5-9018e64a4549_1200x500.png&quot;,&quot;srcNoWatermark&quot;:null,&quot;fullscreen&quot;:null,&quot;imageSize&quot;:null,&quot;height&quot;:500,&quot;width&quot;:1200,&quot;resizeWidth&quot;:null,&quot;bytes&quot;:null,&quot;alt&quot;:null,&quot;title&quot;:null,&quot;type&quot;:null,&quot;href&quot;:null,&quot;belowTheFold&quot;:false,&quot;topImage&quot;:true,&quot;internalRedirect&quot;:null,&quot;isProcessing&quot;:false,&quot;align&quot;:null,&quot;offset&quot;:false}" class="sizing-normal" alt="" srcset="https://substackcdn.com/image/fetch/$s_!S2hP!,w_424,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fbucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com%2Fpublic%2Fimages%2F3c913dcc-b869-4a26-a6a5-9018e64a4549_1200x500.png 424w, https://substackcdn.com/image/fetch/$s_!S2hP!,w_848,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fbucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com%2Fpublic%2Fimages%2F3c913dcc-b869-4a26-a6a5-9018e64a4549_1200x500.png 848w, https://substackcdn.com/image/fetch/$s_!S2hP!,w_1272,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fbucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com%2Fpublic%2Fimages%2F3c913dcc-b869-4a26-a6a5-9018e64a4549_1200x500.png 1272w, https://substackcdn.com/image/fetch/$s_!S2hP!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fbucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com%2Fpublic%2Fimages%2F3c913dcc-b869-4a26-a6a5-9018e64a4549_1200x500.png 1456w" sizes="100vw" fetchpriority="high"></picture><div class="image-link-expand"><div class="pencraft pc-display-flex pc-gap-8 pc-reset"></div></div></div></a></figure></div><ol><li><p>Last Week in Longevity</p></li><li><p>Longevity Futures</p></li><li><p>Capital Raise Radar</p></li><li><p>Longevity Jobs</p></li><li><p>Tweet of the Week</p></li></ol><p><em>*<strong>Disclaimer</strong>: None of this should be taken as financial advice. It is for educational purposes only.</em></p><p><em>**<strong>Resources</strong>: <a href="https://longevitymarketcap.com/longevity-trial-tracker/">Longevity Clinical Trial Tracker </a>// <a href="https://longevitylist.com/longevity-industry-database/">Longevity Industry Database</a>. If you are a longevity company, investor, VC firm, fund, non-profit, and want to be added to the database please <a href="mailto:nathan@longevitymarketcap.com">email me</a>. <strong>It‚Äôs free</strong>.</em></p><p><em>***<strong>Fundraising </strong>If you know of anything that indicates longevity companies that are currently looking for funding please <a href="mailto:nathan@longevitymarketcap.com">email me</a>. I will add them to the ‚ÄúFundraising Radar‚Äù section of the newsletter and <a href="https://longevitylist.com/longevity-industry-database/">database</a>. <strong>It‚Äôs free.</strong></em></p><p><em>****<strong> Hiring? </strong><a href="mailto:nathan@longevitylist.com">Email me</a> the links to your job postings and I will put them on LongevityList.com (and select jobs in this newsletter). <strong>It‚Äôs free.</strong></em></p><h2><strong>üì¢ </strong>Announcements&nbsp;</h2><ul><li><p><strong><a href="https://onepercentbet.org">The 1% Bet for Longevity-- a website initiative.</a> </strong>Building on my newsletter last week and a suggestion from one of my readers, Matthew Busel, I have launched the <strong>1% Bet for Longevity.</strong> The initiative seeks to convince as many people as possible to publicly promise to <strong>commit at least 1% of their net worth</strong> towards funding longevity biotechnology companies or research. Longevity biotechnology holds the potential for incredible upside. And yet despite this much less than 1% of the $400T total global wealth has been directed towards longevity. <br><br>I want to change this --and I am going to start by leading by example. You can stand up for longevity too by going to the website <a href="https://onepercentbet.org">onepercentbet.org</a> and submitting your name on the form. Your name will be added to the public list of signatories after moderation. <br><br>Isn‚Äôt more life worth more betting on? Spread the word.</p></li><li><p>PS: I have a <a href="https://www.patreon.com/nathancheng">Patreon account</a>. My mission is to grow a wave of passionate people building, funding, and championing technologies that extend healthy human lifespan. If you believe in me, my work, and my mission please consider supporting.</p></li></ul><h2><strong>üìù</strong> Last Week in Longevity</h2><ul><li><p><strong><a href="https://bioagelabs.com/BioAge_BGE-175_phase2_initiation_Press_Release.pdf">BioAge announces the launch of their 2nd clinical trial --reversing immune system aging in COVID-19 patients.</a></strong> AI/ML drug discovery startup BioAge has officially begun its trial of BGE-175 for COVID-19 patients over the age of 60. BGE-175 is a small molecule antagonist of the prostaglandin D2 DP1 receptor, which regulates immune function. BGE-175 is a drug licensed from Shionogi, a Japanese pharma company. Top-line data from the </p></li></ul>...</source>
      </div>

      <div class="read-full-article">
        <a href="https://sub.longevitymarketcap.com/p/024-march-23-2021-longevity-marketcap" class="read-button" target="_blank" rel="noopener">
          Read full article on Longevity Marketcap &rarr;
        </a>
        <p class="copyright-note">
          This excerpt is provided for preview purposes.
          Full article content is available on the original publication.
        </p>
      </div>
    </article>
  
  </main>
</body>
</html>